Skip to main content
Top
Published in: AIDS and Behavior 6/2013

01-07-2013 | Original Paper

Feasibility, Acceptability and Preliminary Efficacy of an Online Peer-to-Peer Social Support ART Adherence Intervention

Authors: Keith J. Horvath, J. Michael Oakes, B. R. Simon Rosser, Gene Danilenko, Heather Vezina, K. Rivet Amico, Mark L. Williams, Jane Simoni

Published in: AIDS and Behavior | Issue 6/2013

Login to get access

Abstract

This study describes the results of an online social support intervention, called “Thrive with Me” (TWM), to improve antiretroviral therapy (ART) adherence. HIV-positive gay or bisexually-identified men self-reporting imperfect ART adherence in the past month were randomized to receive usual care (n = 57) or the eight-week TWM intervention (n = 67). Self-reported ART outcome measures (0–100 % in the past month) were collected at baseline, post-intervention, and 1-month follow-up. Follow-up assessment completion rate was 90 %. Participants rated (1–7 scale) the intervention high in information and system quality and overall satisfaction (Means ≥ 5.0). The intervention showed modest effects for the overall sample. However, among current drug-using participants, the TWM (vs. Control) group reported significantly higher overall ART adherence (90.1 vs. 57.5 % at follow-up; difference = 31.1, p = 0.02) and ART taken correctly with food (81.6 vs. 55.7 % at follow-up; difference = 47.9, p = 0.01). The TWM intervention appeared feasible to implement, acceptable to users, and demonstrated greatest benefits for current drug users.
Literature
1.
go back to reference The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293–9.CrossRef The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293–9.CrossRef
2.
go back to reference Cohen MS, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCrossRef Cohen MS, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCrossRef
3.
go back to reference Prejean J, et al. Estimated HIV incidence in the United States, 2006–2009. PLoS One. 2011;6(8):e17502.PubMedCrossRef Prejean J, et al. Estimated HIV incidence in the United States, 2006–2009. PLoS One. 2011;6(8):e17502.PubMedCrossRef
4.
go back to reference Centers for Disease Control and Prevention, HIV Surveillance Report: Diagnoses of HIV Infection and AIDS in the United States and Dependent Areas, 2010, 2012. Centers for Disease Control and Prevention, HIV Surveillance Report: Diagnoses of HIV Infection and AIDS in the United States and Dependent Areas, 2010, 2012.
5.
go back to reference Mills EJ, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.PubMedCrossRef Mills EJ, et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med. 2006;3(11):e438.PubMedCrossRef
6.
go back to reference Mugavero MJ, et al. Failure to establish HIV care: characterizing the “no show” phenomenon. Clin Infect Dis. 2007;45(1):127–30.PubMedCrossRef Mugavero MJ, et al. Failure to establish HIV care: characterizing the “no show” phenomenon. Clin Infect Dis. 2007;45(1):127–30.PubMedCrossRef
7.
go back to reference Simoni J, et al. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S23–35.PubMedCrossRef Simoni J, et al. Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S23–35.PubMedCrossRef
8.
go back to reference Simoni J, et al. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003;11(6):185–98.PubMed Simoni J, et al. Antiretroviral adherence interventions: a review of current literature and ongoing studies. Top HIV Med. 2003;11(6):185–98.PubMed
9.
go back to reference Thompson MA, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an international association of physicians in AIDS care panel. Ann Intern Med. 2012;156(11):817–33.PubMedCrossRef Thompson MA, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an international association of physicians in AIDS care panel. Ann Intern Med. 2012;156(11):817–33.PubMedCrossRef
10.
go back to reference Saberi P, Johnson MO. Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One. 2011;6(11):e27533.PubMedCrossRef Saberi P, Johnson MO. Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One. 2011;6(11):e27533.PubMedCrossRef
11.
go back to reference Page TF, et al. A cost analysis of an internet-based medication adherence intervention for people living with HIV. J Acquir Immune Defic Syndr. 2012;60(1):1–4.PubMedCrossRef Page TF, et al. A cost analysis of an internet-based medication adherence intervention for people living with HIV. J Acquir Immune Defic Syndr. 2012;60(1):1–4.PubMedCrossRef
12.
go back to reference Pellowski JA, Kalichman SC. Recent advances (2011–2012) in technology-delivered interventions for people living with HIV. Curr HIV/AIDS Rep. 2012;9(4):326–34.PubMedCrossRef Pellowski JA, Kalichman SC. Recent advances (2011–2012) in technology-delivered interventions for people living with HIV. Curr HIV/AIDS Rep. 2012;9(4):326–34.PubMedCrossRef
13.
go back to reference Fisher JD, et al. Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows project. AIDS Behav. 2011;15(8):1635–46.PubMedCrossRef Fisher JD, et al. Computer-based intervention in HIV clinical care setting improves antiretroviral adherence: the LifeWindows project. AIDS Behav. 2011;15(8):1635–46.PubMedCrossRef
14.
go back to reference Portnoy DB, et al. Computer-delivered interventions for health promotion and behavioral risk reduction: a meta-analysis of 75 randomized controlled trials, 1988–2007. Prev Med. 2008;47(1):3–16.PubMedCrossRef Portnoy DB, et al. Computer-delivered interventions for health promotion and behavioral risk reduction: a meta-analysis of 75 randomized controlled trials, 1988–2007. Prev Med. 2008;47(1):3–16.PubMedCrossRef
15.
go back to reference Noar SM, Black HG, Pierce LB. Efficacy of computer technology-based HIV prevention interventions: a meta-analysis. AIDS. 2009;23(1):107–15.PubMedCrossRef Noar SM, Black HG, Pierce LB. Efficacy of computer technology-based HIV prevention interventions: a meta-analysis. AIDS. 2009;23(1):107–15.PubMedCrossRef
17.
go back to reference Fox S. Peer-to-peer healthcare: many people-especially those living with chronic or rare diseases-use online connections to supplement professional medical advice. Washington DC: Pew Research Center’s Internet & American Life Project; 2011. Fox S. Peer-to-peer healthcare: many people-especially those living with chronic or rare diseases-use online connections to supplement professional medical advice. Washington DC: Pew Research Center’s Internet & American Life Project; 2011.
18.
go back to reference Horvath K, et al. Technology use and reasons to participate in social networking health websites among people living with HIV in the US. AIDS Behav. 2012;16(4):900–10.PubMedCrossRef Horvath K, et al. Technology use and reasons to participate in social networking health websites among people living with HIV in the US. AIDS Behav. 2012;16(4):900–10.PubMedCrossRef
19.
go back to reference Rosser BS, et al. Reducing HIV risk behavior of men who have sex with men through persuasive computing: results of the Men’s INTernet Study-II. AIDS. 2010;24(13):2099–107.PubMedCrossRef Rosser BS, et al. Reducing HIV risk behavior of men who have sex with men through persuasive computing: results of the Men’s INTernet Study-II. AIDS. 2010;24(13):2099–107.PubMedCrossRef
20.
go back to reference Potosky D. The internet knowledge (iKnow) measure. Comput Hum Behav. 2007;23(6):2760–77.CrossRef Potosky D. The internet knowledge (iKnow) measure. Comput Hum Behav. 2007;23(6):2760–77.CrossRef
21.
go back to reference Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1992;1:385–401.CrossRef Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1992;1:385–401.CrossRef
22.
go back to reference Zhang W, et al. Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada. PLoS One. 2012;7(7):e40793.PubMedCrossRef Zhang W, et al. Validating a shortened depression scale (10 item CES-D) among HIV-positive people in British Columbia, Canada. PLoS One. 2012;7(7):e40793.PubMedCrossRef
23.
go back to reference Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–96.PubMedCrossRef Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385–96.PubMedCrossRef
24.
go back to reference Wong MD, et al. The association between life chaos, health care use, and health status among HIV-infected persons. J Gen Intern Med. 2007;22(9):1286–91.PubMedCrossRef Wong MD, et al. The association between life chaos, health care use, and health status among HIV-infected persons. J Gen Intern Med. 2007;22(9):1286–91.PubMedCrossRef
25.
go back to reference Emlet CA. Measuring stigma in older and younger adults with HIV/AIDS: an analysis of an HIV stigma scale and initial exploration of subscales. Res Soc Work Pract. 2005;15:291–300.CrossRef Emlet CA. Measuring stigma in older and younger adults with HIV/AIDS: an analysis of an HIV stigma scale and initial exploration of subscales. Res Soc Work Pract. 2005;15:291–300.CrossRef
26.
go back to reference Saunders JB, et al. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption–II. Addiction. 1993;88(6):791–804.PubMedCrossRef Saunders JB, et al. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption–II. Addiction. 1993;88(6):791–804.PubMedCrossRef
27.
go back to reference DeLone WH, McLean ER. The DeLone and McLean model of information systems success: a ten-year update. J Manag Inf Syst. 2003;19(4):9–30. DeLone WH, McLean ER. The DeLone and McLean model of information systems success: a ten-year update. J Manag Inf Syst. 2003;19(4):9–30.
28.
go back to reference DeLone WH, McLean ER. Information systems success: the quest for the dependent variable. Inf Syst Res. 1992;3(1):60–95.CrossRef DeLone WH, McLean ER. Information systems success: the quest for the dependent variable. Inf Syst Res. 1992;3(1):60–95.CrossRef
29.
go back to reference Simoni J, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45.PubMedCrossRef Simoni J, et al. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45.PubMedCrossRef
30.
go back to reference Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16(2):269–77.PubMedCrossRef Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16(2):269–77.PubMedCrossRef
31.
go back to reference Begg C, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276(8):637–9.PubMedCrossRef Begg C, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276(8):637–9.PubMedCrossRef
32.
go back to reference Dimitrov DM, Rumrill PD Jr. Pretest-posttest designs and measurement of change. Work. 2003;20(2):159–65.PubMed Dimitrov DM, Rumrill PD Jr. Pretest-posttest designs and measurement of change. Work. 2003;20(2):159–65.PubMed
33.
go back to reference Gottman JM, Rushe RH. The analysis of change: issues, fallacies, and new ideas. J Consult Clin Psychol. 1993;61(6):907–10.PubMedCrossRef Gottman JM, Rushe RH. The analysis of change: issues, fallacies, and new ideas. J Consult Clin Psychol. 1993;61(6):907–10.PubMedCrossRef
34.
go back to reference Bangsberg DR, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3.PubMedCrossRef Bangsberg DR, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3.PubMedCrossRef
35.
go back to reference Pasternak AO, et al. Modest non-adherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma. J Infect Dis. 2012;206(9):1443–52.PubMedCrossRef Pasternak AO, et al. Modest non-adherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma. J Infect Dis. 2012;206(9):1443–52.PubMedCrossRef
36.
go back to reference Rivet Amico K, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a Research Synthesis of Trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285–97.PubMedCrossRef Rivet Amico K, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a Research Synthesis of Trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285–97.PubMedCrossRef
37.
go back to reference Anderson PL, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.PubMedCrossRef Anderson PL, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.PubMedCrossRef
Metadata
Title
Feasibility, Acceptability and Preliminary Efficacy of an Online Peer-to-Peer Social Support ART Adherence Intervention
Authors
Keith J. Horvath
J. Michael Oakes
B. R. Simon Rosser
Gene Danilenko
Heather Vezina
K. Rivet Amico
Mark L. Williams
Jane Simoni
Publication date
01-07-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 6/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0469-1

Other articles of this Issue 6/2013

AIDS and Behavior 6/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.